Stock LWEL LUCKWEL PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Luckwel Pharmaceuticals Inc.

Equities

LWEL

US54959L1017

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
LUCKWEL PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
LUCKWEL PHARMACEUTICALS : Changes in Registrant's Certifying Accountant, Non-Reliance on Previous Financials, Audits or Interim Review, Financial Statements and Exhibits (form 8-K/A)
AQ
LUCKWEL PHARMACEUTICALS INC. : Changes in Registrant's Certifying Accountant, Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
AQ
LUCKWEL PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
AQ
LUCKWEL PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
Luckwel Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended June 30, 2020
CI
LUCKWEL PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
AQ
Luckwel Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended March 31, 2020
CI
LUCKWEL PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
AQ
Luckwel Pharmaceuticals Inc. announced that it expects to receive $0.075 million in funding from Bounty Company Limited
CI
LUCKWEL PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
AQ
Luckwel Pharmaceuticals Inc. announced that it expects to receive $0.12 million in funding
CI
LUCKWEL PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
LUCKWEL PHARMACEUTICALS INC. : Unregistered Sale of Equity Securities (form 8-K)
AQ
LUCKWEL PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
LUCKWEL PHARMACEUTICALS INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
AQ
LUCKWEL PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities (form 8-K)
AQ
LUCKWEL PHARMACEUTICALS INC. : Other Events (form 8-K)
AQ
Luckwel Pharmaceuticals Inc. Announces Address Changes
CI
Luckwel Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter Ended December 31, 2019
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LWEL Stock
  4. News Luckwel Pharmaceuticals Inc.